Professor Kenji Hamaoka

Kyoto Prefectural University of Medicine, Kyoto (Japan)

Follow

Contributor content

Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease.

Presentation

Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease.

ESC 365 is supported by

novartis

Explore sponsored resources